Technology | March 29, 2010

Wireless, Real-Time ECG Aids Diagnostic Decisions

March 29, 2010 – A new multiparameter ambulatory monitoring solution that transmits electrocardiogram (ECG) and other clinical modalities via cellular network, enables real-time data analysis for more expedient triaging of critical patients. ScottCare Corp. just launched TeleSentry, the latest innovation to its CardioView Dx suite of cardiovascular diagnostic solutions.

TeleSentry is a single device that allows clinicians to effectively manage large volumes of patient data. The platform helps clinicians efficiently process and refine data, providing the insight cardiologists need to make sound diagnostic decisions.

Advancements in arrhythmia monitoring technology are greatly enhancing the quality of patient data. The transmission of ECG and other physiological data via cellular network reduces the likelihood of human error, and unlike acoustic arrhythmia transmissions, is completely noise free. Productivity is also improved, as technicians no longer need to guide patients through a manual data transfer process.

The device also auto-triggers and auto-transmits on bradycardia, tachycardia, pause and atrial fibrillation, without relying on patient intervention. The advanced atrial fibrillation algorithm in TeleSentry combines several identification methods of recognition to minimize false positives, achieving unmatched results in a real patient population. The system can also monitor three, five or true 12 lead ECG.

The software provides tools to determine if early intervention is needed. The ECG can be displayed for any active patient in just a few clicks. A clinician can run a query on almost any criteria to gain insight into the activities surrounding an arrhythmia event. Event parameters can also be configured remotely to ensure only the most relevant data for each patient is captured. Extended patient data of up to 30 days can be analyzed with seamless integration into ScottCare’s Holter analysis system.

For more information: www.scottcare.com

Related Content

FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...
EKG With Artificial Intelligence Reliably Detects Heart Failure Precursor
News | ECG | January 08, 2019
January 8, 2019 — A Mayo Clinic study finds that applying...
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use an adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.

Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer. 

Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the effe
HeartSciences MyoVista ECG Device Shows Promise in Detecting Abnormal Cardiac Function
News | ECG | April 27, 2018
HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous...
ECG Study of NBA Players Shows Need for Sport-Specific Normative Data and Guidelines
News | ECG | December 08, 2017
Cardiologists at NewYork-Presbyterian/Columbia University Irving Medical Center compared electrocardiographic findings...
HeartSciences Announces CE Mark and European Launch of MyoVista High Sensitivity ECG

Just as a Doppler radar color image shows the energy of a storm, MyoVista provides physicians a detailed visual image of the energy distribution during the cardiac cycle.

News | ECG | August 22, 2017
HeartSciences announced the European launch of the MyoVista high sensitivity electrocardiograph (hsECG) Testing Device...
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG | August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG | July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Overlay Init